Partnering
Today, approximately half of Roche and Genentech’s pipeline and marketed medicines derive from successful collaborations with companies and institutions around the world.
Today, approximately half of Roche and Genentech’s pipeline and marketed medicines derive from successful collaborations with companies and institutions around the world.